Cover Image
Market Research Report

Analysis of the European Contract Research Outsourcing Markets

Published by Frost & Sullivan Product code 249892
Published Content info
Delivery time: 1-2 business days
Back to Top
Analysis of the European Contract Research Outsourcing Markets
Published: September 5, 2012 Content info:


Opportunities in the Rapidly Changing Clinical Drug Development Outsourcing Market Across Europe

The scope of this research service is to provide an in-depth analysis of the contract research opportunities available in the European therapeutic market. It analyses the revenue potential, market dynamics, trends and competitive structure. The European Contract Research Outsourcing (CRO) revenues have been derived from the preclinical and clinical services offered by contract research organisations to pharmaceutical and biotechnology sponsors in conducting clinical trials. The markets analysed in this research service have been approached from a service provider's point of view. The CRO market has been exclusively segmented based on stages of clinical trials, therapeutic services and geographies.

Table of Contents
Product Code: M856-01-00-00-00

Table of Contents

1. Executive Summary

Snapshot of the Contract Research Organisations Market

  • Summary

2. Market Overview

Overview of the Contract Research Organisations Market

  • Overview

3. External Challenges: Drivers and Restraints- Total Market

Overview of the Markert Drivers and Restraints

  • Analysis of the Market Drivers and Restraints

4. Forecasts and Trends - Total CRO Market

Overview of the Revenue Forecasts and Trends

  • Analysis of the Market Forecasts and Trends

5. Market Share and Competitve Analysis - Total CRO Market

Market Share and Competitive Analysis: Contract Research Organisations Market

  • Analysis of the Market Share and Competitive Analysis

6. Segment Analysis by Stages of Clinical Development

Segmentation Based on Stages of Clinical Development

  • Analytical Laboratory Testing
  • Preclinical Trials
  • Phase I Trials
  • Phase II Trials
  • Phase III Trials
  • Other Stages

7. Segment Analysis by Therapeutics

Segmentation Based on the Area of Therapy

  • Cardiovascular Therapeutics
  • CNS Disorders Therapeutics
  • Endocrine and Metabolic Disorders Therapeutics
  • Oncology Therapeutics
  • Infectious Diseases Therapeutics
  • Other Therapeutics

8. Segmentation by Geography

Analysis by Geographic Regions

  • Germany Breakdown
  • France Breakdown
  • The United Kingdom Breakdown
  • Spain Breakdown
  • Italy Breakdown

9. The Last Word


  • The Last Word
  • Legal Disclaimer

10. Appendix

Support Data Tables

  • Market Engineering Methodology
  • Database of Key Industry Participants
  • Decision Support Database
Back to Top